Inflammation, Allergy, and Immunology Journal Articles from the International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Topic search: ALLERGY/IMMUNOLOGY/INFLAMMATION

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Inflammation, Allergy, and Immunology Journal Articles
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Psoriasis Topical Ointment Allen Loyd V Jr	Jan/Feb 2023 Pg. 57
Compounding with Biotechnology Products, Part 2: Product-specific Considerations Allen Loyd V Jr	Nov/Dec 2022 Pg. 446-466
Curcumin 2% Topical Gel Allen Loyd V Jr	Nov/Dec 2022 Pg. 509
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Riepl Mike	Sep/Oct 2022 Pg. 364-368
Compounded Medications and Probiotics for Irritable Bowel Syndrome Narváez Katherine Rivera, Thompson Tara	Sep/Oct 2022 Pg. 378-384
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Allen Loyd V Jr	Sep/Oct 2022 Pg. 430
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Riepl Mike	Jul/Aug 2022 Pg. 270-274
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Harrington Amy, Williams LaVonn	Jul/Aug 2022 Pg. 293-296
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion Allen Loyd V Jr	Jul/Aug 2022 Pg. 318
Dexamethasone 1 mg/mL in Oral Mix Allen Loyd V Jr	Jul/Aug 2022 Pg. 320
Indomethacin 1% Topical Gel Allen Loyd V Jr	Jul/Aug 2022 Pg. 325-326
Psoriasis Topical Ointment Allen Loyd V Jr	Jul/Aug 2022 Pg. 329
Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude	Jul/Aug 2022 Pg. 336-341
Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle Allen Loyd V Jr	May/Jun 2022 Pg. 236
Sirolimus 0.1% Ointment Allen Loyd V Jr	May/Jun 2022 Pg. 240
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	May/Jun 2022 Pg. 241
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Riepl Mike	Mar/Apr 2022 Pg. 94-98
Mesalamine 100-mg/mL Suspension Enema Allen Loyd V Jr	Mar/Apr 2022 Pg. 144
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice	Mar/Apr 2022 Pg. 150-154
Ascorbic Acid 10% in Anhydrous PEG ointment Allen Loyd V Jr	Jan/Feb 2022 Pg. 53
Diclofenac Sodium 1%-15% Topical Gel Allen Loyd V Jr	Jan/Feb 2022 Pg. 55
Mometasone Furoate 0.1% Lotion Allen Loyd V Jr	Jan/Feb 2022 Pg. 57
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Riepl Mike	Sep/Oct 2021 Pg. 372-377
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 416
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli	Sep/Oct 2021 Pg. 422-426
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A	Sep/Oct 2021 Pg. 431-439
Budesonide 0.0.25% Mucoadhesive Gel Allen Loyd V Jr	Jul/Aug 2021 Pg. 323
Hydrocortisone 2-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 325
Tacrolimus 0.1% Topical Microemulsion Allen Loyd V Jr	Jul/Aug 2021 Pg. 328
Calculations Stockton Shelly J	May/Jun 2021 Pg. 230-231
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 234
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Hui Ada, Yin Jian, Liu Wei, Zheng Kai	May/Jun 2021 Pg. 246-257
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 47
Design and Performance of an Inexpensive Water Activity Meter Gilda Sagar S, Schober Joseph M, McPherson Timothy	Jan/Feb 2021 Pg. 48-51
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 315
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Allen Loyd V Jr	Jul/Aug 2020 Pg. 316
Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2020 Pg. 317
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Allen Loyd V Jr	Jul/Aug 2020 Pg. 320
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S	Jul/Aug 2020 Pg. 337-345
Dexamethasone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 225
Prednisolone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 229
Low-dose Naltrexone Therapy for Psoriasis Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander	Mar/Apr 2020 Pg. 94-96
Feasibility Study of Asthma Cream Kuang Andrew	Mar/Apr 2020 Pg. 163-167
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 57
LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 59
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 490
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 491
Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2019 Pg. 410
Calculations Stockton Shelly J	May/Jun 2019 Pg. 229
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2019 Pg. 231
Flunisolide Nasal Spray Allen Loyd V Jr	May/Jun 2019 Pg. 233
Methotrexate 2-mg/mL Oral Solution Allen Loyd V Jr	May/Jun 2019 Pg. 235
Dexamethasone 2 mg/g Topical Paste, Veterinary Allen Loyd V Jr	Mar/Apr 2019 Pg. 149
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Mar/Apr 2019 Pg. 150
Tacrolimus 0.5 mg/mL in Oral Mix Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 153
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Williams LaVonn A	Jan/Feb 2019 Pg. 14-21
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Jan/Feb 2019 Pg. 52
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 53
Hydrocortisone 2 mg/mL in Inorpha Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 495
Prednisone 5 mg/mL ir Oral Mix Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 497
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don	Jul/Aug 2018 Pg. 270-278
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Williams LaVonn	Jul/Aug 2018 Pg. 284-287
Budesonide 1-mg//10-mL Mucolox Oral Suspensions Allen Loyd V Jr	Jul/Aug 2018 Pg. 317
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Jul/Aug 2018 Pg. 319
Spironolactone 5-mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 152
Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet) Allen Loyd V Jr	Mar/Apr 2018 Pg. 153
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 51
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Jan/Feb 2018 Pg. 54
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 58
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H	Jan/Feb 2018 Pg. 66-75
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Nov/Dec 2017 Pg. 494
Tolmetin 400-mg Capsules Allen Loyd V Jr	Nov/Dec 2017 Pg. 497
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream Allen Loyd V Jr	Jul/Aug 2017 Pg. 312
Tacrolimus 0.06% Ophthalmic Drops Allen Loyd V Jr	Jul/Aug 2017 Pg. 319
Tranilast 8% Pluronic Lecithin Organogel Gel Allen Loyd V Jr	Jul/Aug 2017 Pg. 321
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel	Jul/Aug 2017 Pg. 322-329
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V	Jul/Aug 2017 Pg. 334-338
Meloxicam 1% Topical Gel Allen Loyd V Jr	May/Jun 2017 Pg. 235
Azathioprine 10-mg/mL Oral Suspension Allen Loyd V Jr	Mar/Apr 2017 Pg. 146
Infliximab 1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2017 Pg. 62
Naproxen 5% Cream Allen Loyd V Jr	Sep/Oct 2016 Pg. 410
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa	Jul/Aug 2016 Pg. 333-337
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Allen Loyd V Jr	May/Jun 2016 Pg. 228
Indomethacin Gel Allen Loyd V Jr	May/Jun 2016 Pg. 230
Montelukast Sodium 5-mg Fast-Dissolving Film Allen Loyd V Jr	May/Jun 2016 Pg. 232
Blue Goo Anti-Itch Gel Allen Loyd V Jr	Mar/Apr 2016 Pg. 144
Medicated Polyox Bandage for Skin Ulcers Allen Loyd V Jr	Mar/Apr 2016 Pg. 146
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Choo Winnie	Jan/Feb 2016 Pg. 6-10
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Allen Loyd V Jr	Jan/Feb 2016 Pg. 51
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr	Nov/Dec 2015 Pg. 508
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin	Sep/Oct 2015 Pg. 357-365
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Allen Loyd V Jr	Sep/Oct 2015 Pg. 405
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Allen Loyd V	Jul/Aug 2015 Pg. 333
Stability of Prednisone in Oral Mix Suspending Vehicle Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim	Jul/Aug 2015 Pg. 337-339
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Allen Loyd V Jr	May/Jun 2015 Pg. 243
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin	May/Jun 2015 Pg. 261-267
Azathioprine 50-mg Capsules Allen Loyd V Jr	Jan/Feb 2015 Pg. 61
Hydroxychloroquine Sulfate 200-mg Capsules Allen Loyd V Jr	Jan/Feb 2015 Pg. 66
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica	Jan/Feb 2015 Pg. 73-77
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari	Sep/Oct 2014 Pg. 370-377
Ephedrine Sulfate 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 411
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H	Sep/Oct 2014 Pg. 418-426
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard	Sep/Oct 2014 Pg. 427-431
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis Reisacher William, Rudner Shara, Kotik Viktoriya	Jul/Aug 2014 Pg. 287-290
Choline Magnesium Trisalicylate Liquid Allen Loyd V Jr	Jul/Aug 2014 Pg. 327
Denileukin Diftitox 150-mcg/mL Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 328
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Peacock Gina F, Sauvageot Jurgita, Addo Richard T	Jul/Aug 2014 Pg. 348-350
Cortisone Acetate 25-mg Capsules Allen Loyd V Jr	Nov/Dec 2013 Pg. 501
Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate) Allen Loyd V Jr	Nov/Dec 2013 Pg. 504
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease McElhiney Linda F	Sep/Oct 2013 Pg. 380-383
Indomethacin 1-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 419
Methotrexate 25-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 421
Phenylephrine Hydrochloride 10-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 422
Mercaptopurine 75-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 234
Prednisone 10-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 236
Adrenal Fatigue Allen Loyd V Jr	Jan/Feb 2013 Pg. 39-44
Ibuprofen 10-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 67
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K	Jan/Feb 2013 Pg. 74-85 View Sample
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Zur Eyal	Nov/Dec 2012 Pg. 462-469
Azathioprine 10-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 502
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Zur Eyal	Sep/Oct 2012 Pg. 386-393
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Zur Eyal	Jul/Aug 2012 Pg. 288-293
Betamethasone 0.6-mg/5-mL Syrup Allen Loyd V Jr	Jul/Aug 2012 Pg. 332
Diphenhydramine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 334
Ketorolac Tromethamine 15-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 337
Treatment and Prevention of Insect Bites: Mosquitoes Williams LaVonn A, Allen Loyd V Jr	May/Jun 2012 Pg. 210-218
Famotidine 10-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 242
Naloxone Hydrochloride 1-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 244
Prochlorperazine 5-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 246
Ranitidine 25-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 247
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste Dudley Richard, McDowell Brean, Mahl Carissa, Sarkar Arindam Basu	May/Jun 2012 Pg. 258-261
Promethazine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 163
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Zur Eyal	Jan/Feb 2012 Pg. 22-33
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Zur Eyal	Nov/Dec 2011 Pg. 458-463
Oxandrolone 2-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2011 Pg. 505
Thioguanine 20-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2011 Pg. 506
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Kaiser Jeanette, Kramer Irene	Nov/Dec 2011 Pg. 515-520
Rebamipide Rectal Enema Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 424
Cromolyn Sodium 50-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2011 Pg. 336
Hydrocortisone 100-mg/60-mL Retention Enema Allen Loyd V Jr	Jul/Aug 2011 Pg. 338
Magnesium Sulfate Paste Allen Loyd V Jr	Jul/Aug 2011 Pg. 339
Treating Inner Ear Disorders with Intratympanic Drug Administration McElhiney Linda F	Jul/Aug 2011 Pg. 302-307
Methylprednisolone 4-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2011 Pg. 340
Oxandrolone 1-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2011 Pg. 341
Treatment Options for Psoriasis Williams LaVonn A, Humphreys Erica	May/Jun 2011 Pg. 204-213
Diclofenac Sodium 1% Topical Gel Allen Loyd V Jr	May/Jun 2011 Pg. 243
Ibuprofen 5% Topical Cream Allen Loyd V Jr	May/Jun 2011 Pg. 244
Triamcinolone 0.1% Lotion Allen Loyd V Jr	May/Jun 2011 Pg. 249
Current Concepts in the Treatment of Recurrent Aphthous Ulcers Bramwell Bethany L, Williams LaVonn A	Jan/Feb 2011 Pg. 13-18
Diclofenac Sodium 10-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2011 Pg. 64
Hydrocortisone Acetate 1% Gel, Alcohol-Free Allen Loyd V Jr	Jan/Feb 2011 Pg. 65
Ibuprofen 5% Gel Allen Loyd V Jr	Jan/Feb 2011 Pg. 66
Methotrexate 30-mg/g Topical Gel Allen Loyd V Jr	Jan/Feb 2011 Pg. 68
Piroxicam 1% Gel Allen Loyd V Jr	Jan/Feb 2011 Pg. 69
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form Gupta Vishnu D, Gupta Vikas S	Jan/Feb 2011 Pg. 78-80
Capsaicin 0.05% Clear Medication Stick Allen Loyd V Jr	Nov/Dec 2010 Pg. 517
Ketoprofen 2% Oral Gel Allen Loyd V Jr	Nov/Dec 2010 Pg. 521
Bromhexine Hydrochloride 0.8-mg/mL Syrup Allen Loyd V Jr	Nov/Dec 2010 Pg. 516
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Allen Loyd V Jr	Nov/Dec 2010 Pg. 520
Alpha-Bisabolol Mouthwash Allen Loyd V Jr	Sep/Oct 2010 Pg. 420
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Santoveña A, Llabrés M, Fariña JB	Sep/Oct 2010 Pg. 430-435
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Allen Loyd V Jr	Sep/Oct 2010 Pg. 427
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops Allen Loyd V Jr	Jul/Aug 2010 Pg. 336
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient McElhiney Linda F	Mar/Apr 2010 Pg. 112-115
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) Allen Loyd V Jr	Mar/Apr 2010 Pg. 151
Ketoprofen 100-mg/5-mL Mouth Rinse Allen Loyd V Jr	Jan/Feb 2010 Pg. 68
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2010 Pg. 74
A Review of Stomatitis and Treatment in Cats Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E	Sep/Oct 2009 Pg. 372-381
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Williams LaVonn A, Fokken Dawn	Sep/Oct 2009 Pg. 386-389
An Abridged History of Aspirin Vance Dwight A	Sep/Oct 2009 Pg. 404-409
Dexamethasone and Furosemide Injection Allen Loyd V Jr	Jul/Aug 2009 Pg. 335
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection Allen Loyd V Jr	Mar/Apr 2009 Pg. 157
Nicotine Rectal Enema Allen Loyd V Jr	Mar/Apr 2009 Pg. 158
Diphenhydramine Hydrochloride 25-mg Gelatin Troches Allen Loyd V Jr	Jan/Feb 2009 Pg. 69
Excipient Choices for Special Populations Nagel-Edwards Karen M, Ko James Y	Sep/Oct 2008 Pg. 426-430
Flurandrenolide Topical Film Allen Loyd V Jr	Sep/Oct 2008 Pg. 451
Compounding Challenges for Immunocompromised Patients McElhiney Linda F	Nov/Dec 2008 Pg. 482-487
Zirconium Oxide Lotion Allen Loyd V Jr	Jul/Aug 2008 Pg. 364
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol	Jul/Aug 2008 Pg. 295-304
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization Westrick Salisa C, Felkey Bill G	Jul/Aug 2008 Pg. 334-337
Tretinoin and (-)Alpha-Bisabolol Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 360
Tretinoin and Dexpanthenol Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 361
Cyclosporine Topical Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 64
Diclofenac Sodium 1% Soft-Patch Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 65
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 66
Flosulide 10-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2008 Pg. 69
Piroxicam 1% Soft-Patch Lipophilic Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 71
Piroxicam 1% Soft-Patch Topical Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 72
Betamethasone Valerate 0.1% Topical Gel Allen Loyd V Jr	Sep/Oct 2007 Pg. 419
Diclofenac Sodium 75-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2007 Pg. 421
Hydrocortisone 0.5% Ethanolic Gel Allen Loyd V Jr	Sep/Oct 2007 Pg. 423
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form Gupta Vishnu D	Jul/Aug 2007 Pg. 347-348
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Gupta Vishnu D	May/Jun 2007 Pg. 259-261
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous Allen Loyd V Jr	Mar/Apr 2007 Pg. 154
Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh Vail Jane	Mar/Apr 2007 Pg. 132-135
Triprolidine Hydrochloride 0.25-mg/mL Syrup Allen Loyd V Jr	Mar/Apr 2007 Pg. 163
Dexamethasone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 72
Prednisone 10-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 77
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 78
Cyclophosphamide 2-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 454
Indomethacin 2-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 458
Terbutaline Sulfate 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 460
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Bigeleisen Paul E	Sep/Oct 2006 Pg. 392-395
Dapsone 2-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 300
Probiotic Therapy, Part 2: Clinical Perspectives Vail Jane	May/Jun 2006 Pg. 195-200
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A, Zhang Yanping	May/Jun 2006 Pg. 234-236
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together Gupta Vishnu D	May/Jun 2006 Pg. 237-239
Mycophenolate Mofetil 50-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 141
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives Vail Jane	Mar/Apr 2006 Pg. 107-111
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery Heim Bob	Jan/Feb 2006 Pg. 14-18 View Sample
Mercaptopurine 50-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 64
Dexamethasone Oral Powder 10-mg Units, Veterinary Allen Loyd V Jr	May/Jun 2005 Pg. 226